These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 21175580)

  • 21. Roles of Brain Angiotensin II in Cognitive Function and Dementia.
    Mogi M; Iwanami J; Horiuchi M
    Int J Hypertens; 2012; 2012():169649. PubMed ID: 23304450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale for double renin-angiotensin-aldosterone system blockade.
    Unger T; Stoppelhaar M
    Am J Cardiol; 2007 Aug; 100(3A):25J-31J. PubMed ID: 17666194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous activation of renin-angiotensin system impairs cognitive function in renin/angiotensinogen transgenic mice.
    Inaba S; Iwai M; Furuno M; Tomono Y; Kanno H; Senba I; Okayama H; Mogi M; Higaki J; Horiuchi M
    Hypertension; 2009 Feb; 53(2):356-62. PubMed ID: 19047580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The renin-angiotensin systems: evolving pharmacological perspectives for cerebroprotection.
    Magy L; Vincent F; Faure S; Messerli FH; Wang JG; Achard JM; Fournier A
    Curr Pharm Des; 2005; 11(25):3275-91. PubMed ID: 16250855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecule-specific effects of angiotensin II-receptor blockers independent of the renin-angiotensin system.
    Kurtz TW; Pravenec M
    Am J Hypertens; 2008 Aug; 21(8):852-9. PubMed ID: 18535538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current topic of next generation of angiotensin II type 1 receptor blockers].
    Mogi M; Horiuchi M
    Nihon Rinsho; 2012 Sep; 70(9):1621-6. PubMed ID: 23012813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?
    Culman J; Jacob T; Schuster SO; Brolund-Spaether K; Brolund L; Cascorbi I; Zhao Y; Gohlke P
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):949-959. PubMed ID: 28669009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of the renin-angiotensin system and the prevention of stroke.
    Schrader J; Kulschewski A; Dendorfer A
    Am J Cardiovasc Drugs; 2007; 7(1):25-37. PubMed ID: 17355164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A; Divchev D; Luchtefeld M; Schieffer B
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valsartan ameliorates the constitutive adipokine expression pattern in mature adipocytes: a role for inverse agonism of the angiotensin II type 1 receptor in obesity.
    Hasan AU; Ohmori K; Hashimoto T; Kamitori K; Yamaguchi F; Ishihara Y; Ishihara N; Noma T; Tokuda M; Kohno M
    Hypertens Res; 2014 Jul; 37(7):621-8. PubMed ID: 24599011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice.
    Iwanami J; Mogi M; Tsukuda K; Min LJ; Sakata A; Jing F; Iwai M; Horiuchi M
    J Hypertens; 2010 Aug; 28(8):1730-7. PubMed ID: 20498620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can the renin-angiotensin system protect against stroke? A focus on angiotensin II receptor blockers.
    Epstein BJ; Gums JG
    Pharmacotherapy; 2005 Apr; 25(4):531-9. PubMed ID: 15977915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of central PPAR-γ attenuates angiotensin II-induced hypertension.
    Yu Y; Xue BJ; Wei SG; Zhang ZH; Beltz TG; Guo F; Johnson AK; Felder RB
    Hypertension; 2015 Aug; 66(2):403-11. PubMed ID: 26101342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial peroxisome proliferator-activated receptor agonist angiotensin receptor blockers. Potential multipronged strategy in stroke prevention.
    Towfighi A; Ovbiagele B
    Cerebrovasc Dis; 2008; 26(2):106-12. PubMed ID: 18560212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term treatment of stroke-prone spontaneously hypertensive rats with an AT1 receptor blocker protects against hypertensive end-organ damage by prolonged inhibition of the renin-angiotensin system.
    Hamaguchi R; Takemori K; Inoue T; Masuno K; Ito H
    Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1151-5. PubMed ID: 18518883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain-Derived Neurotrophic Factor Knockdown Blocks the Angiogenic and Protective Effects of Angiotensin Modulation After Experimental Stroke.
    Fouda AY; Alhusban A; Ishrat T; Pillai B; Eldahshan W; Waller JL; Ergul A; Fagan SC
    Mol Neurobiol; 2017 Jan; 54(1):661-670. PubMed ID: 26758277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are angiotensin receptor blockers neuroprotective?
    Thöne-Reineke C; Zimmermann M; Neumann C; Krikov M; Li J; Gerova N; Unger T
    Curr Hypertens Rep; 2004 Aug; 6(4):257-66. PubMed ID: 15257859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II subtype 1 receptor blockers and renal function.
    Toto R
    Arch Intern Med; 2001 Jun; 161(12):1492-9. PubMed ID: 11427096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
    Yamagishi S; Takeuchi M
    Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.
    Werner C; Baumhäkel M; Teo KK; Schmieder R; Mann J; Unger T; Yusuf S; Böhm M
    Clin Res Cardiol; 2008 Jul; 97(7):418-31. PubMed ID: 18454336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.